Zum Inhalt springen
Sponsorship
Die MVF-Knowledge-HubsFrisch aus der Forschung. Täglich aktualisiert!

Suchen Sie in Hunderten nationaler und internationaler Datenbanken nach dem neuesten Studienwissen der angegebenen Themengebiete und/oder lassen Sie sich werktäglich per Newsletter informieren. Die Newsfeeds werden auf deutsch übersetzt and nach Übertragbarkeit auf das deutsche Gesundheits-/Versorgungssystem ausgewählt:

Zu den Knowledge-Hubs

Abstracts by keywords: comparison of countries

The contribution of pharmacy pharmacists to optimizing drug therapy safety - a comparison of German, Australian and Swiss models

Medicines are effective and efficient as a form of therapy in the outpatient and inpatient care of patients, provided they are used correctly. However, with increasing therapy options through new drug developments and the simultaneous use of several drugs (polypharmacy), the complexity of drug therapy increases. In particular, chronically ill and multimorbid patients are often treated with several different medications, which increases the risk of adverse drug reactions (ADRs) and drug-related harm. The risk of ADRs in these patients increases due to age-associated changes in pharmacokinetics and pharmacodynamics, in addition to potential drug interactions. Ensuring drug therapy safety (AMTS), especially for chronic patients, represents a particular challenge in drug supply.

24.01.2013

Do you want to leave us already?

Subscribe to our newsletter quickly. Then you can be sure that you won't miss anything.